Drug Development Studies Targeting Neurological Disorders, Particularly Alzheimer’s Disease

References

1. Anil Yilmaz, Murat Koca, Mehmet Boga, Adnan Kurt, Turan Ozturk. Synthesis of Novel Oxime and Benzofuran Chemical Frameworks Possessing Potent Anticholinesterase Activity: A SAR Study Related to Alzheimer Disease.ChemistrySelect2023830e20230205810.1002/slct.202302058
   [Google Scholar]
2. Anil Yilmaz, Murat Koca, Selami Ercan, Ozden Ozgun Acar. Mehmet Boga, Alaattin Sen, Adnan Kurt. Amelioration potential of synthetic oxime chemical cores against multiple sclerosis and Alzheimer’s diseases: Evaluation in aspects of in silico and in vitro experiments.Journal of Molecular Structure20241318113919310.1016/j.molstruc.2024.139193
   [Google Scholar]
3. Joshi, Nachiket; Khadse, Prachi; Jadhav, Shivani Histone deacetylase inhibition in Alzheimer’s disease: molecular mechanisms, therapeutic potential, and future perspectives.Curr. Top. Med. Chem.202510.2174/0115680266360664250606110220 40530721
   [Google Scholar]
4. Kumar, Deepak; Wal, Pranay; Wal, Ankita; Lari, Mohd Qasid; Ashesh, Astik Manju; Kumar, Dileep; Singh, Sandeep Kumar; Singh, Bhupendra; Kumar, Ajay Novel nanoformulations to overcome obstacles in herbal drug delivery for Alzheimer’s disease.Curr. Top. Med. Chem.202510.2174/0115680266362594250527112018 40589006
   [Google Scholar]
5. Güneş, Ahmet; Meletli, Furkan; Danış, Özkan; Ağırtaş, Mehmet Salih; Yalçın, Bahattin Synthesis of new axially coumarin disubstituted silicon(IV) phthalocyanines, investigation of their DNA-binding properties and inhibitory activities on AChE and BuChE.Curr. Top. Med. Chem.202510.2174/0115680266368541250311084659 40192047
   [Google Scholar]
6. Akocak, Suleyman; Lolak, Nebih; Ammara, Andrea; Güler, Özen Özensoy; Supuran, Claudiu T. Exploring the carbonic anhydrase activation properties of 4-arylazo-3,5-diamino-1H-pyrazoles against hCA I, II, IV, and VII isoenzymes.Curr. Top. Med. Chem.202510.2174/0115680266373008250723064558 40735986
   [Google Scholar]
7. Ergin, Ahmet Doğan Nanotechnological approaches for mitochondrial targeting in neurodegenerative diseases.Curr. Top. Med. Chem.202510.2174/0115680266397447250723073446 40735987
   [Google Scholar]